Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?

被引:36
作者
Kehrmann, J. [1 ]
Kaase, M. [2 ]
Szabados, F. [2 ]
Gatermann, S. G. [2 ]
Buer, J. [1 ]
Rath, P-M [1 ]
Steinmann, J. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, D-45147 Essen, Germany
[2] Ruhr Univ Bochum, Dept Med Microbiol, Bochum, Germany
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; MINIMUM INHIBITORY CONCENTRATION; METHICILLIN-RESISTANT; BACTEREMIA; INFECTIONS; DAPTOMYCIN; OUTCOMES; SUSCEPTIBILITY; EFFICACY; FEATURES;
D O I
10.1007/s10096-010-1140-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to assess the vancomycin MIC distribution for MRSA blood culture isolates over a period of six years in Germany. The study examined 287 MRSA isolates from blood cultures collected at several hospitals in two German cities between 2004 and 2009. The vancomycin MIC was determined by Etest. Genotypic features of the MRSA strains with vancomycin MIC a parts per thousand yenaEuro parts per thousand 1 mg/L were determined by semiautomated repetitive-sequence-based polymerase chain reaction. The range of vancomycin MIC as determined by Etest was 0.25 to 2.0 mg/L. The geometric mean MIC increased by 1.34-fold in city A over the study period (p < 0.05), but there was no meaningful change in city B (a 1.09-fold increase, p > 0.05). Furthermore, in city A a shift in vancomycin MICs occurred as an increase in the percentage of isolates with MIC a parts per thousand yenaEuro parts per thousand 1 mg/L from period one (2004-2006) to period two (2007-2009) (p < 0.0001). Typing results showed that in city A a single clone was predominant (55% of the creep isolates). In this study, the creep phenomenon seems to be a regional problem. We suggest that all hospitals should monitor their local status of elevated vancomycin MICs in invasive MRSA isolates.
引用
收藏
页码:677 / 683
页数:7
相关论文
共 37 条
  • [1] Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage
    Alos, Juan-Ignacio
    Garcia-Canas, Ana
    Garcia-Hierro, Paloma
    Rodriguez-Salvanes, Francisco
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (04) : 773 - 775
  • [2] Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002)
    Biedenbach, DJ
    Moet, GJ
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 59 - 69
  • [3] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
    Charles, PGP
    Ward, PB
    Johnson, PDR
    Howden, BP
    Grayson, ML
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 448 - 451
  • [4] Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis
    Cosgrove, SE
    Sakoulas, G
    Perencevich, EN
    Schwaber, MJ
    Karchmer, AW
    Carmeli, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) : 53 - 59
  • [5] Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Fowler, Vance G., Jr.
    Boucher, Helen W.
    Corey, G. Ralph
    Abrutyn, Elias
    Karchmer, Adolf W.
    Rupp, Mark E.
    Levine, Donald P.
    Chambers, Henry F.
    Tally, Francis P.
    Vigliani, Gloria A.
    Cabell, Christopher H.
    Link, Arthur Stanley
    DeMeyer, Ignace
    Filler, Scott G.
    Zervos, Marcus
    Cook, Paul
    Parsonnet, Jeffrey
    Bernstein, Jack M.
    Price, Connie Savor
    Forrest, Graeme N.
    Faetkenheuer, Gerd
    Gareca, Marcelo
    Rehm, Susan J.
    Brodt, Hans Reinhardt
    Tice, Alan
    Cosgrove, Sara E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07) : 653 - 665
  • [6] The problem with glycopeptides
    Gould, I. M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (01) : 1 - 3
  • [7] Geographic Distribution of Staphylococcus aureus Causing Invasive Infections in Europe: A Molecular-Epidemiological Analysis
    Grundmann, Hajo
    Aanensen, David M.
    van den Wijngaard, Cees C.
    Spratt, Brian G.
    Harmsen, Dag
    Friedrich, Alexander W.
    [J]. PLOS MEDICINE, 2010, 7 (01)
  • [8] High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
    Hidayat, Levita K.
    Hsu, Donald I.
    Quist, Ryan
    Shriner, Kimberly A.
    Wong-Beringer, Annie
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) : 2138 - 2144
  • [9] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136
  • [10] Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong
    Ho, Pak-Leung
    Lo, Pui-Ying
    Chow, Kin-Hung
    Lau, Eric H. Y.
    Lai, Eileen L.
    Cheng, Vincent C. C.
    Kao, Richard Y.
    [J]. JOURNAL OF INFECTION, 2010, 60 (02) : 140 - 145